In Washington, DC and state capitals around the country, Lupus Foundation of America advocates tell their stories and urge their elected officials to support policies that improve the lives of people ...

A lupus diagnosis can profoundly affect many aspects of a man’s life, from sense of identity and mental health to the way one engages with loved ones and the broader community. While lupus is often ...

Supporting lupus patients and advocates in Arizona.

There have been many advancements in the treatment and diagnosis of lupus. With proper care and a healthy lifestyle many people with lupus can live a normal life. When lupus is fatal, it’s usually due ...

We are excited to present the second West Region Purple Power Party of 2025! RSVP today to join fellow lupus warriors, caregivers, and advocates throughout Washington, Oregon, Montana, Idaho, ...

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab (Benlysta®) treatment for children ages five years and older with active ...

The Michael Jon Barlin Pediatric Lupus Research program provides funding for research projects that have the potential to significantly advance the field of or impact the lives of children living with ...

Researchers from EMD Serono and global collaborators shared promising results from Cohort B of the phase II trial of the WILLOW study.

The Lupus Foundation of America continues to lead advocacy efforts to protect and strengthen funding for the National Institutes of Health (NIH), which is the largest funder of lupus research.